Physician profile
Andre A Panossian
NPI 1710177845
$1,229.16
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.67 · 2020: $89.40 · 2021: $1,002 · 2022: $29.97 · 2023: $13.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $950.09 | 2020-2021 | |
| Checkpoint Surgical, INC | $116.86 | 2020-2022 | |
| Allergan, INC. | $54.39 | 2021 | |
| Intercept Pharmaceuticals, INC. | $42.72 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.49 | 2019 | |
| Galderma Laboratories, L.P. | $26.11 | 2019-2023 | |
| Kls-Martin L.P. | $5.50 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Panossian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.